Author

Yael Feferman

Tel Aviv UniversityORCID 0000-0002-4914-4553Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Adva Levy‐BardaiD· 1 shared Effi YeoshouaiD· 1 shared Efrat Merhavi-ShohamiD· 1 shared Eran SadotiD· 1 shared Eyal GreenbergiD· 1 shared Gal MarkeliD· 1 shared Gilli Galore-HaskeliD· 1 shared Goni Hout‐SiloniiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adva Levy‐BardaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Novel immunotherapy for multiple solid cancers using an Anti-HVEM blocking monoclonal antibody

Gilli Galore-Haskel, Efrat Merhavi-Shoham, Mika Shapiro, Roni Bareli, Naama Dror, Sivan Seliktar-Ofir, Katerina Shamalov, Adva Levy‐Barda, Goni Hout‐Siloni, Jacob Schachter, Eran Sadot, Ram Eitan, Iris Barshack, Shay Golan, Yael Feferman, , Gal Markel

This paper develops and tests Anti-4CB1, an anti-HVEM monoclonal antibody, showing enhanced anti-tumor activity in vitro and in vivo, particularly when combined with Anti-PD1, and correlates HVEM expression with treatment response.

bioRxiv · Dec 16, 2024 · PreprintCancer Biology